PTC Therapeutics CEO Matthew Klein sold company stock under a trading plan.
3 reports, 1 independent
Updated Sep 13
Gone quiet
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
PTC Therapeutics CEO Matthew Klein sold company stock under a trading plan.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
PTC Therapeutics
pharmaceutical company
Nothing else this week.